These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38631846)

  • 1. Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period.
    Polo Y La Borda J; Castañeda S; Heras-Recuero E; Sánchez-Alonso F; Plaza Z; García Gómez C; Ferraz-Amaro I; Sanchez-Costa JT; Sánchez-González OC; Turrión-Nieves AI; Perez-Alcalá A; Pérez-García C; González-Juanatey C; Llorca J; Gonzalez-Gay MA;
    RMD Open; 2024 Apr; 10(2):. PubMed ID: 38631846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up.
    Polo Y la Borda J; Castañeda S; Sánchez-Alonso F; Plaza Z; García-Gómez C; Ferraz-Amaro I; Erausquin C; Valls-García R; Fábregas MD; Delgado-Frías E; Mas AJ; González-Juanatey C; Llorca J; González-Gay MA;
    Semin Arthritis Rheum; 2024 Jun; 66():152442. PubMed ID: 38555727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid plaques as predictors of cardiovascular events in patients with Rheumatoid Arthritis. Results from a 5-year-prospective follow-up study.
    Corrales A; Vegas-Revenga N; Rueda-Gotor J; Portilla V; Atienza-Mateo B; Blanco R; Castañeda S; Ferraz-Amaro I; Llorca J; González-Gay MA
    Semin Arthritis Rheum; 2020 Dec; 50(6):1333-1338. PubMed ID: 32416998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of QRISK3 and SCORE as predictors of carotid plaques in patients with rheumatoid arthritis.
    Corrales A; Vegas-Revenga N; Atienza-Mateo B; Corrales-Selaya C; Prieto-Peña D; Rueda-Gotor J; Portilla V; Blanco R; Castañeda S; Ferraz-Amaro I; Llorca J; González-Gay MA
    Rheumatology (Oxford); 2021 Jun; 60(6):2801-2807. PubMed ID: 33249513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study.
    Navarini L; Margiotta DPE; Caso F; Currado D; Tasso M; Angeletti S; Ciccozzi M; Scarpa R; Afeltra A; Costa L
    PLoS One; 2018; 13(10):e0205506. PubMed ID: 30308025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
    Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
    Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis.
    Navarini L; Margiotta DPE; Costa L; Currado D; Tasso M; Angeletti S; Ciccozzi M; Scarpa R; Afeltra A; Caso F
    Clin Rheumatol; 2019 Apr; 38(4):971-976. PubMed ID: 30680532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up.
    Martín-Martínez MA; Castañeda S; Sánchez-Alonso F; García-Gómez C; González-Juanatey C; Sánchez-Costa JT; Belmonte-López MA; Tornero-Molina J; Santos-Rey J; Sánchez González CO; Quesada E; Moreno-Gil MP; Cobo-Ibáñez T; Pinto-Tasnde JA; Babío-Herráez J; Bonilla G; Juan-Mas A; Manero-Ruiz FJ; Romera-Baurés M; Bachiller-Corral J; Chamizo-Carmona E; Uriarte-Ecenarro M; Barbadillo C; Fernández-Carballido C; Aurrecoechea E; Möller-Parrera I; Llorca J; González-Gay MA;
    Rheumatology (Oxford); 2021 Jun; 60(6):2906-2915. PubMed ID: 33254222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk reclassification according to six cardiovascular risk algorithms and carotid ultrasound in psoriatic arthritis patients.
    Galarza-Delgado DA; Azpiri-Lopez JR; Colunga-Pedraza IJ; Guajardo-Jauregui N; Rodriguez-Romero AB; Lugo-Perez S; Cardenas-de la Garza JA; Arvizu-Rivera RI; Flores-Alvarado DE; Ilizaliturri-Guerra O; Garcia-Arellano G; Garza-Acosta AC
    Clin Rheumatol; 2022 May; 41(5):1413-1420. PubMed ID: 34826020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk assessment according to a national calibrated score risk index in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors.
    Rosales Alexander JL; Cantero-Hinojosa J; Salvatierra J; Magro Checa C; González-Gay MÁ; Raya Álvarez E
    Joint Bone Spine; 2014 Mar; 81(2):164-8. PubMed ID: 23932927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trøndelag Health Study.
    Gulati AM; Semb AG; Rollefstad S; Romundstad PR; Kavanaugh A; Gulati S; Haugeberg G; Hoff M
    Ann Rheum Dis; 2016 May; 75(5):819-24. PubMed ID: 25814652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study.
    Nissen CB; Hørslev-Petersen K; Primdahl J
    Rheumatol Int; 2017 Jan; 37(1):113-120. PubMed ID: 27889826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.
    Horreau C; Pouplard C; Brenaut E; Barnetche T; Misery L; Cribier B; Jullien D; Aractingi S; Aubin F; Joly P; Le Maître M; Ortonne JP; Paul C; Richard MA
    J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():12-29. PubMed ID: 23845149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study.
    Lam SHM; Cheng IT; Li EK; Wong P; Lee J; Yip RM; Yim CW; Ying SK; Li M; Li TK; Lee AP; Tam LS
    Ann Rheum Dis; 2020 Oct; 79(10):1320-1326. PubMed ID: 32737113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease.
    Carrillo-Palau M; Hernández-Camba A; Ramos L; Vela M; Arranz L; Hernández Alvarez-Buylla N; Alonso-Abreu I; Hernández-Pérez A; Hernández-Guerra M; Palazuelos C; Llorca J; González-Gay MÁ; Ferraz-Amaro I
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study.
    Urruticoechea-Arana A; Martín-Martínez MA; Castañeda S; Piedra CA; González-Juanatey C; Llorca J; Díaz-Gonzalez F; González-Gay MA;
    Arthritis Res Ther; 2015 Aug; 17(1):211. PubMed ID: 26271333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE.
    Panopoulos S; Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
    Lupus Sci Med; 2023 Mar; 10(1):. PubMed ID: 36868585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib.
    Kristensen LE; Strober B; Poddubnyy D; Leung YY; Jo H; Kwok K; Vranic I; Fleishaker DL; Fallon L; Yndestad A; Gladman DD
    Ther Adv Musculoskelet Dis; 2023; 15():1759720X221149965. PubMed ID: 36777695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index.
    Gómez-Vaquero C; Robustillo M; Narváez J; Rodríguez-Moreno J; González-Juanatey C; Llorca J; Nolla JM; González-Gay MA
    Clin Rheumatol; 2012 Jan; 31(1):35-9. PubMed ID: 21567119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.